Bodycote plc (LON:BOY)’s share price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 678.03 ($8.86) and traded as high as GBX 701 ($9.16). Bodycote shares last traded at GBX 701 ($9.16), with a volume of 112,770 shares traded.
BOY has been the topic of several recent research reports. JPMorgan Chase & Co. boosted their price objective on shares of Bodycote from GBX 635 ($8.30) to GBX 650 ($8.49) and gave the stock an “underweight” rating in a research report on Tuesday, February 9th. Barclays boosted their target price on shares of Bodycote from GBX 620 ($8.10) to GBX 715 ($9.34) and gave the company an “equal weight” rating in a research note on Monday, November 30th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of GBX 656.36 ($8.58).
The stock’s 50 day moving average price is GBX 728.67 and its 200 day moving average price is GBX 678.03. The company has a current ratio of 0.62, a quick ratio of 0.56 and a debt-to-equity ratio of 17.83. The company has a market cap of £1.38 billion and a price-to-earnings ratio of 30.99.
Bodycote Company Profile (LON:BOY)
Bodycote plc provides heat treatment and thermal processing services worldwide. The company operates through Aerospace, Defence & Energy; and Automotive & General Industrial segments. It offers heat treatment services, including altering the microstructure of metals and alloys, such as steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, and vacuum and honeycomb brazing; and hot isostatic pressing (HIP) services, including powdermet technology, isostatic pressing, and HIP supporting.
Read More: Price Target
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.